Following a positive advisory committee meeting outcome regarding the Janssen Biotech Inc. COVID-19 vaccine, the U.S. Food and Drug Administration has informed the sponsor that it will rapidly work toward finalization and issuance of an emergency use authorization
Read more: FDA Statement on Vaccines and Related Biological Products Advisory Committee Meeting